These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16352699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
    Yasar S, Schindler CW, Thorndike EB, Szelenyi I, Goldberg SR.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):1-6. PubMed ID: 8473997
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of deprenyl for cocaine-like discriminative stimulus effects in rats.
    Yasar S, Schindler CW, Thorndike EB, Goldberg SR.
    Eur J Pharmacol; 1994 Jul 11; 259(3):243-50. PubMed ID: 7982450
    [Abstract] [Full Text] [Related]

  • 5. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    Engberg G, Elebring T, Nissbrandt H.
    J Pharmacol Exp Ther; 1991 Nov 11; 259(2):841-7. PubMed ID: 1658311
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.
    Yasar S, Gaal J, Justinova Z, Bergman J.
    Psychopharmacology (Berl); 2005 Oct 11; 182(1):95-103. PubMed ID: 15990999
    [Abstract] [Full Text] [Related]

  • 7. A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
    Yasar S, Gaál J, Panlilio LV, Justinova Z, Molnár SV, Redhi GH, Schindler CW.
    Psychopharmacology (Berl); 2006 Jan 11; 183(4):413-21. PubMed ID: 16292593
    [Abstract] [Full Text] [Related]

  • 8. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB, Tipton KF.
    Parkinsonism Relat Disord; 2002 Mar 11; 8(4):247-53. PubMed ID: 12039419
    [Abstract] [Full Text] [Related]

  • 9. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A, Brewer F, Johnson ES, Mallard N, Hartig F, Taylor S, Corn TH.
    J Neural Transm (Vienna); 2003 Nov 11; 110(11):1241-55. PubMed ID: 14628189
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
    Yoshida T, Yamada Y, Yamamoto T, Kuroiwa Y.
    Xenobiotica; 1986 Feb 11; 16(2):129-36. PubMed ID: 3083608
    [Abstract] [Full Text] [Related]

  • 11. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Feb 11; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic aspects of deprenyl effects.
    Magyar K, Tóthfalusi L.
    Pol J Pharmacol Pharm; 1984 Feb 11; 36(4):373-84. PubMed ID: 6441926
    [Abstract] [Full Text] [Related]

  • 13. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S, Grasing K.
    Pharmacol Biochem Behav; 2006 Dec 11; 85(4):675-88. PubMed ID: 17157368
    [Abstract] [Full Text] [Related]

  • 14. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F.
    Br J Pharmacol; 1987 Feb 11; 90(2):335-45. PubMed ID: 3103805
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
    Knoll J, Miklya I.
    Arch Int Pharmacodyn Ther; 1994 Feb 11; 328(1):1-15. PubMed ID: 7893186
    [Abstract] [Full Text] [Related]

  • 17. The influence of metabolism on the MAO-B inhibitory potency of selegiline.
    Haberle D, Szökõ E, Magyar K.
    Curr Med Chem; 2002 Jan 11; 9(1):47-51. PubMed ID: 11860347
    [Abstract] [Full Text] [Related]

  • 18. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan 11; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 19. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 11; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 20. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
    Timár J, Knoll B.
    Arch Int Pharmacodyn Ther; 1986 Jan 11; 279(1):50-60. PubMed ID: 3083795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.